Biomedical Engineering Reference
In-Depth Information
101. Shen H, Ackerman AL, Cody V et al (2006) Enhanced and prolonged cross-presentation
following endosomal escape of exogenous antigens encapsulated in biodegradable
nanoparticles. Immunology 117:78-88
102. Uto T, Wang X, Sato K et al (2007) Targeting of antigen to dendritic cells with poly
( g -glutamic acid) nanoparticles induce antigen-specific humoral and cellular immunity.
J Immunol 178:2979-2986
103. Uto T, Akagi T, Hamasaki T et al (2009) Modulation of innate and adaptive immunity by
biodegradable nanoparticles. Immunol Lett 125:46-52
104. Akagi T, Kim H, Akashi M (2010) pH-dependent disruption of erythrocyte membrane by
amphiphilic poly(amino acid) nanoparticles. J Biomater Sci Polym Edn 21:315-328
105. Lutsiak ME, Robinson DR, Coester C et al (2002) Analysis of poly(D, L-lactic-co-glycolic
acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res
19:1480-1487
106. Elamanchili P, Diwan M, Cao M et al (2004) Characterization of poly(D, L-lactic-co-glycolic
acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Vaccine 22:2406-2412
107. Copland MJ, Baird MA, Rades T et al (2003) Liposomal delivery of antigen to human
dendritic cells. Vaccine 21:883-890
108. Cohen JA, Beaudette TT, Tseng WW et al (2009) T-cell activation by antigen-loaded pH-
sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem 20:111-119
109. Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad
Sci USA 103:4930-4934
110. Champion JA, Mitragotri S (2009) Shape induced inhibition of phagocytosis of polymer
particles. Pharm Res 26:244-249
111. Reddy ST, Swartz MA, Hubbell JA (2006) Targeting dendritic cells with biomaterials:
developing the next generation of vaccines. Trends Immunol 27:573-579
112. Jones KS (2008) Biomaterials as vaccine adjuvants. Biotechnol Prog 24:807-814
113. Babensee JE (2007) Interaction of dendritic cells with biomaterials. Semin Immunol
20:101-108
114. Jilek S, Merkle HP, Walter E (2005) DNA-loaded biodegradable microparticles as vaccine
delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 57:377-390
115. Black M, Trent A, Tirrell M et al (2010) Advances in the design and delivery of peptide
subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines 9:157-173
116. Kim H, Uto T, Akag T et al (2010) Amphiphilic poly(amino acid) nanoparticles induce size-
dependent dendritic cell maturation. Adv Funct Mater 20:3925-3931
117. Akagi T, Shima F, Akashi M (2011) Intracellular degradation and distribution of protein-
encapsulated amphiphilic poly(amino acid) nanoparticles. Biomaterials 32:4959-4967
118. Kim TW, Lee TY, Bae HC et al (2007) Oral administration of high molecular mass poly-
g -glutamate induces NK cell-mediated antitumor immunity. J Immunol 179:775-780
119. Lee TY, Kim YH, Yoon SW et al (2009) Oral administration of poly- g -glutamate induces TLR4-
and dendritic cell-dependent antitumor effect. Cancer Immunol Immunother 58:1781-1794
120. Tamayo I, Irache JM, Mansilla C et al (2010) Poly(anhydride) nanoparticles act as active Th1
adjuvants through Toll-like receptor exploitation. Clin Vaccine Immunol 17:1356-1362
121. Yoshida M, Babensee JE (2004) Poly(lactic- co -glycolic acid) enhances maturation of human
monocyte-derived dendritic cells. J Biomed Mater Res 71:45-54
122. Jilek S, Ulrich M, Merkle HP et al (2004) Composition and surface charge of DNA-loaded
microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm
Res 21:1240-1247
123. Thiele L, Rothen-Rutishauser B, Jilek S et al (2001) Evaluation of particle uptake in human
blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure
up with macrophages? J Control Release 76:59-71
124. Matsusaki M, Larsson K, Akagi T et al (2005) Nanosphere induced gene expression in human
dendritic cells. Nano Lett 5:2168-2173
Search WWH ::




Custom Search